![Logo for HilleVax Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fcc0ae-2024-07-03-08-06-01.png&w=256&q=100)
HilleVax Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from HilleVax Inc
Access all reports
HilleVax, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. The company’s primary product under development is HIL-214, a virus-like particle-based vaccine candidate aimed at preventing moderate-to-severe acute gastroenteritis caused by norovirus infection. HilleVax has been working on advancing this vaccine through clinical trials, with efforts to evaluate its safety and efficacy across different age groups. Hillevax is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for HilleVax Inc
![Disclaimer
We caut](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fhillevax-inc-corporate-presentation-ee9085edf68c0ee4%2F2.png&w=3840&q=75)
![Logo for HilleVax Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fcc0ae-2024-07-03-08-06-01.png&w=128&q=100)
Corporate Presentation
HilleVax Inc
![Norovirus in the new](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fhillevax-inc-corporate-presentation-ee9085edf68c0ee4%2F4.png&w=3840&q=75)
![Logo for HilleVax Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fcc0ae-2024-07-03-08-06-01.png&w=128&q=100)
Corporate Presentation
HilleVax Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
HLVX
Country
🇺🇸 United States